What does a GLP-1 program actually cost at Alinwell?

You cannot find out from the site. The homepage badges semaglutide "from $149/mo" and tirzepatide "from $199/mo", but each program page publishes no price at all — the pricing area reads "Available by consultation". So the advertised figure is a floor with no confirmation anywhere, and the number you will actually pay only appears after you complete the eligibility assessment. If seeing the real price before starting matters to you, Andrew Meds publishes its entire ladder on one page.

Why do the sermorelin and NAD+ prices differ depending on the page?

Because the site disagrees with itself. Alinwell's homepage lists sermorelin at $349/mo and NAD+ at $249/mo; its own peptides page prices the same two products at $249 and $199. We have not been able to establish which is current, so both are worth confirming at checkout before you subscribe. We quote the peptides-page figures on our cards because that page is the one with the full catalog and its per-product detail.

Are the certificates of analysis genuinely useful?

Yes, more than most trust signals in this category. Alinwell's semaglutide page publishes COAs identified by batch and test date — 4 mg/mL tested March 2026 under batch 221336, and 2.5 mg/mL in 2mL tested February 2026 under batch LG343002572. Batch-level identification is what separates a real document from a generic quality claim, because it ties the testing to a specific lot rather than to the product in general. It does not tell you the pharmacy's name, which Alinwell still does not publish.

Is Alinwell the same company as Believe Health or Longevixx?

No — they are three separate LLCs — but they sell one catalog. All sixteen peptide products carry identical names and identical prices across the three sites, with a single exception in the entire list: BPC-157 is $210 on Believe Health and $250 on both Alinwell and Longevixx. The three also run the same website build and the same terms-of-service boilerplate with the operating company's name swapped in. Their GLP-1 pricing is not shared, so comparing them there is meaningful; comparing them on peptides is comparing storefronts.

Does Alinwell serve all 50 states?

It says "telehealth nationwide" and "Telehealth in 50 states" in its marketing, but it publishes no state list anywhere, and no page qualifies the claim with exclusions. Compounded GLP-1 availability genuinely does vary by state, so if you live somewhere with tighter telehealth or compounding rules, confirm during the assessment rather than relying on the blanket claim. Andrew Meds, by contrast, states 44 states rather than claiming all 50, which is the more careful way to publish it.

Updated September 2026

Alinwell review

Batch COAs, gated prices

Publishes batch-level certificates of analysis for the semaglutide it dispenses, then declines to publish what it costs.

Our verdict

Alinwell is the only provider in this batch that publishes certificates of analysis with batch numbers and test dates for the drug it sells — a genuine transparency step almost nobody in compounded GLP-1 takes, and one that speaks to the thing readers most reasonably worry about. It undercuts that with its pricing. The homepage badges semaglutide "from $149/mo" and tirzepatide "from $199/mo", but every program page publishes no price at all, saying only "Available by consultation", and the site disagrees with itself on sermorelin ($349 on the homepage, $249 on the peptides page). Its peptide catalog is also not its own: it is identical, SKU for SKU and price for price, to Believe Health's and Longevixx's. Worth considering for the COAs and the women-first framing; go in expecting to complete an assessment before you learn the price.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →Homepage badges semaglutide from $149/mo, tirzepatide $199/mo; program pages publish no price

At a glance

Category: GLP-1 telehealth
Access: Homepage badges semaglutide from $149/mo, tirzepatide $199/mo; program pages publish no price
Medications: Compounded semaglutide · Compounded tirzepatide
Insurance: Cash-pay, no insurance
Visit: Quiz intake / Async intake
Availability: Telehealth nationwide (no state list published)
Updated: September 2026

What it is

A telehealth weight-care and peptide service written explicitly for women — its own hero reads "GLP-1 weight care for women" — operated by Alinwell LLC. Three GLP-1 programs (semaglutide, tirzepatide and a lower-dose GLP-1 microdose) sit alongside a peptide menu organized into six focus areas: metabolic and body composition, anti-aging and growth hormone, recovery and tissue repair, immune and inflammation, cognitive and neurological, and sexual health and hormones. NAD+ injection is sold within the cognitive line.

How it works

Asynchronous, quiz-led. An eligibility assessment collects goals, history and medications; a licensed provider reviews it and decides whether treatment is appropriate, and the site states plainly that there is no guarantee of treatment or a prescription and that you are charged nothing if you are not approved. Alinwell describes itself as offering telehealth nationwide but publishes no list of states. Products are described as compounded in a U.S. pharmacy, though no pharmacy is named. Where it goes further than its peers is verification: the semaglutide program page publishes certificates of analysis identified by batch — 4 mg/mL tested March 2026, batch 221336, and 2.5 mg/mL 2mL tested February 2026, batch LG343002572.

Pricing transparency

This is the weak part, and it is weak in two distinct ways. First, the GLP-1 prices are advertised but not published: the homepage cards badge semaglutide "FROM $149/MO" and tirzepatide "FROM $199/MO", and a further band lists the microdose program at $149/mo, NAD+ at $249/mo and sermorelin at $349/mo — but each program page itself carries no figure at all, stating only "Available by consultation". So the number you are quoted after the assessment is not visible before it. Second, the site contradicts itself: the homepage lists sermorelin at $349/mo while its own peptides page prices it at $249/mo, and NAD+ appears as $249 on the homepage and $199 on the peptides page. The peptide menu is fully priced, and those figures are firm: MOTS-C $279/mo, tesamorelin $299, tesamorelin/ipamorelin $349, BPC-157 $250, BPC-157 acetate $199, BPC-157/TB500 $299, BPC-157/KPV/TB500 $329, BPC-157/GHK-Cu/KPV/TB500 $379, epithalon $249, GHK-Cu $249, GHK-Cu/epithalon $319, thymosin alpha-1 $299, DSIP $249, DSIP/BPC/CJC $329, semax/selank $299 and PT-141 $249.

Branded vs compounded

Compounded semaglutide and tirzepatide, a lower-dose GLP-1 microdose program, and a broad compounded peptide menu. Alinwell states that compounded medications are not FDA-approved seven times across its pages and that products are compounded in a U.S. pharmacy. On the evidence: the semaglutide and tirzepatide outcome data belongs to the branded products rather than to compounded copies; sermorelin, tesamorelin and CJC-1295/ipamorelin act on the growth-hormone axis, a real mechanism with thin long-term outcome data; BPC-157, TB-500, KPV, DSIP, epithalon and the semax/selank nootropics have little to no controlled human outcome evidence; GHK-Cu has essentially none for the claims usually made; injected NAD+ has no controlled outcome trials, with the randomized data sitting on oral NR/NMN precursors; and PT-141 is approved only for HSDD in premenopausal women.

Pros and watch-outs

What we like

Publishes certificates of analysis with batch numbers and test dates — almost unique on this board
Nothing is charged if a provider does not approve you, stated on the page rather than in terms
Peptide menu fully priced and organized by clinical goal rather than by molecule name
Explicitly built for women rather than retrofitted, which is rare in compounded GLP-1
States that compounded medications are not FDA-approved, repeatedly and in the body copy

Watch-outs

No GLP-1 price is published anywhere — every program page says only "Available by consultation"
The site contradicts itself on price: sermorelin is $349 on the homepage and $249 on /peptides
The peptide catalog is shared with Believe Health and Longevixx at identical prices
No pharmacy named, and no list of states behind the "nationwide" claim

Best for

Women who want a GLP-1 program written for them and who value batch-level certificates of analysis enough to complete an assessment before seeing a price.

Who should look elsewhere

Anyone comparing on price before committing time to an intake, or a reader who wants a catalog that is genuinely this provider's own rather than one shared across three brands.

The evidence behind what Alinwell prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
BPC 157: what the evidence actually shows (and what it doesn't)
The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.
NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
GHK-Cu: the copper peptide between real skincare and overclaim
A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

How Alinwell compares

A few alternatives worth a look, depending on what you’re optimizing for.

Believe Health
Readers comparing the three storefronts that share this catalog on care model, not price
See Believe Health →
Longevixx
Readers who want GLP-1 inside a longevity program and will confirm the price at assessment
See Longevixx →
Andrew Meds
Anyone who wants the prepay ladder and its true monthly cost published on one page
See Andrew Meds →

Compare all providers side by side →

More GLP-1 telehealth reviews: Synergy RxGala HealthDirect MedsStrut HealthCoreAge RxOak Longevity

Nadia Feldman

Access & cost · Reviewed and last verified September 2026

How we assessed this. This review reflects Aminoscope’s own read of Alinwell’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

What does a GLP-1 program actually cost at Alinwell?: You cannot find out from the site. The homepage badges semaglutide "from $149/mo" and tirzepatide "from $199/mo", but each program page publishes no price at all — the pricing area reads "Available by consultation". So the advertised figure is a floor with no confirmation anywhere, and the number you will actually pay only appears after you complete the eligibility assessment. If seeing the real price before starting matters to you, Andrew Meds publishes its entire ladder on one page.
Why do the sermorelin and NAD+ prices differ depending on the page?: Because the site disagrees with itself. Alinwell's homepage lists sermorelin at $349/mo and NAD+ at $249/mo; its own peptides page prices the same two products at $249 and $199. We have not been able to establish which is current, so both are worth confirming at checkout before you subscribe. We quote the peptides-page figures on our cards because that page is the one with the full catalog and its per-product detail.
Are the certificates of analysis genuinely useful?: Yes, more than most trust signals in this category. Alinwell's semaglutide page publishes COAs identified by batch and test date — 4 mg/mL tested March 2026 under batch 221336, and 2.5 mg/mL in 2mL tested February 2026 under batch LG343002572. Batch-level identification is what separates a real document from a generic quality claim, because it ties the testing to a specific lot rather than to the product in general. It does not tell you the pharmacy's name, which Alinwell still does not publish.
Is Alinwell the same company as Believe Health or Longevixx?: No — they are three separate LLCs — but they sell one catalog. All sixteen peptide products carry identical names and identical prices across the three sites, with a single exception in the entire list: BPC-157 is $210 on Believe Health and $250 on both Alinwell and Longevixx. The three also run the same website build and the same terms-of-service boilerplate with the operating company's name swapped in. Their GLP-1 pricing is not shared, so comparing them there is meaningful; comparing them on peptides is comparing storefronts.
Does Alinwell serve all 50 states?: It says "telehealth nationwide" and "Telehealth in 50 states" in its marketing, but it publishes no state list anywhere, and no page qualifies the claim with exclusions. Compounded GLP-1 availability genuinely does vary by state, so if you live somewhere with tighter telehealth or compounding rules, confirm during the assessment rather than relying on the blanket claim. Andrew Meds, by contrast, states 44 states rather than claiming all 50, which is the more careful way to publish it.
Is Alinwell legit?: Alinwell is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: Homepage badges semaglutide from $149/mo, tirzepatide $199/mo; program pages publish no price. It is cash-pay and states it does not bill insurance. What our record does not establish: which states it serves and a single monthly price you can check before an intake. Ask for those in writing before you pay.

Check availability →

Or compare every GLP-1 provider.